Implementing Medical Marijuana Education into Existing Patient Care Practices
Abstract
With implementation of HB 523, there is the potential for a gap in patient care due to strict recommendation parameters for approved cannabinoid-based drugs and marijuana still federally classed as a CI substance. This session is designed to provide pharmacists, in all practicing capacities, with the knowledge and tools needed to assess appropriate use of medications and maintain patient-centered care standards
This paper has been withdrawn.